Clinical Trials on Acute Ischaemic Stroke in Luxembourg

Total 15 results

Wandercraft

Completed

Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident (INSPIRE)

Stroke | Stroke, Acute | Chronic Stroke | Stroke, Subacute

Belgium, France, Luxembourg
CytoSorbents Europe GmbH

Terminated

Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery (CyTation)

Acute Coronary Syndrome

Germany, Luxembourg
UMC Utrecht

Unknown

Randomized "All-comer" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent

Acute Coronary Syndrome | Stable Angina Pectoris

Netherlands, Luxembourg
Luxembourg Institute of Health

Completed

Co-design of a Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 Using Voice (UpcomingVoice)

COVID-19 | Post-Acute COVID-19

Luxembourg
Luxembourg Institute of Health
ViewMind

Recruiting

Digital Cognition Study During Long-COVID (DIGICOG)

COVID-19, Long Haul

Luxembourg
St. Antonius Hospital

Completed

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (POPular-TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Netherlands, Belgium, Czechia, Luxembourg
St. Antonius Hospital

Active, not recruiting

Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Stenosis | Aortic Valve Disease | Thrombosis Embolism | Vascular Complications

Netherlands, Ireland, Belgium, Denmark, Italy, Luxembourg
Robocath

Completed

R-One Efficiency For PCI Evolution With Robotic Assistance (R-EVOLUTION)

Coronary Artery Disease | Percutaneous Coronary Intervention

France, Belgium, Luxembourg, Netherlands
Rennes University Hospital

Recruiting

Effect of Intense Sport Practice in Athletes With Non-ischemic Scar (EISCAR)

Athletes With Isolated Non-ischemic LGE With no Underlying "Labelled" Cardiomyopathy

France, Australia, Belgium, Germany, Luxembourg, United Kingdom
Robbert J de Winter

Unknown

Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent (REMEDEE Reg)

Coronary Artery Disease

Netherlands, Latvia, United Kingdom, Luxembourg, Spain
Seagen Inc.

Terminated

Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia (CASCADE)

Acute Myeloid Leukemia

Korea, Republic of, United States, Spain, Belgium, Germany, Czechia, Hungary, Taiwan, France, Israel, Italy, United Kingdom, Australia, Austria, Poland, Luxembourg
AstraZeneca

Completed

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge (EPICOR)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Unstable Angina | ACS

Brazil, France, Italy, Mexico, Spain, Turkey, United Kingdom, Germany, Poland, Romania, Denmark, Finland, Norway, Argentina, Belgium, Netherlands, Greece, Luxembourg, Slovenia, Venezuela
European Society of Anaesthesiology

Completed

Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe (PERISCOPE)

Complication of Surgical Procedure | Pulmonary Failure | Surgical Complications From General Anesthesia | Postoperative Respiratory Complications | Acute Respiratory Failure, Adult

Belgium, Spain, Albania, Bosnia and Herzegovina, Croatia, Czechia, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Luxembourg, Poland, Portugal, Romania, Russian Federation, Switzerland, Turkey, Ukraine
Stichting Hemato-Oncologie voor Volwassenen Nederland
Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)

Recruiting

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy (HOVON150AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2

Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
Stichting Hemato-Oncologie voor Volwassenen Nederland
Astellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...

Active, not recruiting

A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy (HOVON 156 AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2

Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain

Clinical Trials on Acute Ischaemic Stroke in Luxembourg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations